Insulin pump therapy for pregnancy: a primer

References

• Diabetes care and research in Europe: The Saint Vincent declaration. Diabet Med 1990;7:360.
   PubMed Web of Science ®Google Scholar
• Pregnancy outcomes in the diabetes control and complications trial. Am J Obstet Gynecol 1996;174:1343–1353.
   PubMedGoogle Scholar
• Nordström L, Spetz E, Wallström K, Wålinder O. Metabolic control and pregnancy outcome among women with insulin-dependent diabetes mellitus. A twelve-year follow-up in the country of Jämtland, Sweden. Acta Obstet Gynecol Scand 1998;77:284–289.
   PubMedGoogle Scholar
• McElvy SS, Miodovnik M, Rosenn B, Khoury JC, Siddiqi T, Dignan PS, Tsang RC. A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels. J Matern Fetal Med 2000;9:14–20.
   PubMedGoogle Scholar
• Wylie BR, Kong J, Kozak SE, Marshall CJ, Tong SO, Thompson DM. Normal perinatal mortality in type 1 diabetes mellitus in a series of 300 consecutive pregnancy outcomes. Am J Perinatol 2002;19:169–176.
   PubMedGoogle Scholar
• Platt MJ, Stanisstreet M, Casson IF, Howard CV, Walkinshaw S, Pennycook S, McKendrick O. St Vincent’s Declaration 10 years on: Outcomes of diabetic pregnancies. Diabet Med 2002;19:216–220.
   PubMed Web of Science ®Google Scholar
• Penney GC, Mair G, Pearson DW; Scottish Diabetes in Pregnancy Group. Outcomes of pregnancies in women with type 1 diabetes in Scotland: A national population-based study. BJOG 2003;110:315–318.
   PubMed Web of Science ®Google Scholar
• Dunne F, Brydon P, Smith K, Gee H. Pregnancy in women with type 2 diabetes: 12 years outcome data 1990–2002. Diabet Med 2003;20:743–748.
   PubMedGoogle Scholar
• Vääräsmäki MS, Hartikainen A, Anttila M, Pramila S, Koivisto M. Factors predicting peri- and neonatal outcome in diabetic pregnancy. Early Hum Dev 2000;59:61–70.
   PubMed Web of Science ®Google Scholar
• Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: Nationwide prospective study in the Netherlands. BMJ 2004;328:915.
   PubMed Web of Science ®Google Scholar
• Sharpe PB, Chan A, Haan EA, Hiller JE. Maternal diabetes and congenital anomalies in South Australia 1986–2000: A population-based cohort study. Birth Defects Res Clin Mol teratol 2005;73;605–611.
   PubMedGoogle Scholar
• Jensen DM, Damm P, Moelsted-Pedersen L, Ovesen P, Westergaard JG, Moeller M, Beck-Nielsen H. Outcomes in type 1 diabetic pregnancies: A nationwide, population-based study. Diabetes Care 2004;27:2819–2823.
   PubMed Web of Science ®Google Scholar
• Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998;21:518–524.
   PubMed Web of Science ®Google Scholar
• The Diabetic Control and Complications Trial Research group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–86.
   PubMed Web of Science ®Google Scholar
• The United Kingdom Prospective Diabetes Study Research Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and the risk of complications in patients with type 2 diabetes. Lancet 1998;352:837–853.
   PubMedGoogle Scholar
• Hiéronimus S, Cupelli C, Bongain A, Durand-Réville M, Berthier F, Fénichel P. [Pregnancy in type 1 diabetes: Insulin pump versus intensified conventional therapy]. Gynecol Obstet Fertil 2005;33:389–394.
   PubMedGoogle Scholar
• Lepercq J. [Pregnancy in type 1 diabetes: Insulin pump versus intensified conventional therapy. Gynecol Obstet Fertil 2005;33:389-394]. Gynecol Obstet Fertil 2005;33:955–956.
   PubMedGoogle Scholar
• Gabbe SG, Holing E, Temple P, Brown ZA. Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus. Am J Obstet Gynecol 2000;182:1283–1291.
   PubMed Web of Science ®Google Scholar
• Lapolla A, Dalfrà MG, Masin M, Bruttomesso D, Piva I, Crepaldi C, Tortul C, et al. Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy. Acta Diabetol 2003;40:143–149.
   PubMed Web of Science ®Google Scholar
• Giménez M, Conget I, Nicolau J, Pericot A, Levy I. Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control study. Acta Diabetol 2007;44:34–37.
   PubMed Web of Science ®Google Scholar
• Volpe L, Pancani F, Aragona M, Lencioni C, Battini L, Ghio A, Resi V, et al. Continuous subcutaneous insulin infusion and multiple dose insulin injections in Type 1 diabetic pregnant women: A case-control study. Gynecol Endocrinol 2010;26:193–196.
   PubMed Web of Science ®Google Scholar
• González-Romero S, González-Molero I, Fernández-Abellán M, Domínguez-López ME, Ruiz-de-Adana S, Olveira G, Soriguer F. Continuous subcutaneous insulin infusion versus multiple daily injections in pregnant women with type 1 diabetes. Diabetes Technol Ther 2010;12:263–269.
   PubMed Web of Science ®Google Scholar
• Chen R, Ben-Haroush A, Weismann-Brenner A, Weissman-Brenner A, Melamed N, Hod M, Yogev Y. Level of glycemic control and pregnancy outcome in type 1 diabetes: A comparison between multiple daily insulin injections and continuous subcutaneous insulin infusions. Am J Obstet Gynecol 2007;197:404.e1–404.e5.
   Web of Science ®Google Scholar
• Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: A meta-analysis. Diabetes Care 2003;26:1079–1087.
   PubMed Web of Science ®Google Scholar
• Farrar D, Tuffnell DJ, West J. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst Rev 2007;3: CD005542.
   Google Scholar
• Mukhopadhyay A, Farrell T, Fraser RB, Ola B. Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: A systematic review and metaanalysis of randomized, controlled trials. Am J Obstet Gynecol 2007;197:447–456.
   PubMed Web of Science ®Google Scholar
• Bernasko J. A practical guide to insulin pump therapy for pregnancy. IUniverse Publishing Company. 2010.
   Google Scholar
• Ray JG, O’Brien TE, Chan WS. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: A meta-analysis. QJM 2001;94:435–444.
   PubMed Web of Science ®Google Scholar
• Kalkhoff RK, Kissebah AH, Kim HJ. Carbohydrate and lipid metabolism during normal pregnancy: Relationship to gestational hormone action. Semin Perinatol 1978;2:291–307.
   PubMedGoogle Scholar
• Kalkhoff RK, Richardson BL, Beck P. Relative effects of pregnancy, human placental lactogen and prednisolone on carbohydrate tolerance in normal and subclinical diabetic subjects. Diabetes 1969;18:153–163.
   PubMed Web of Science ®Google Scholar
• Samaan N, Yen SC, Gonzalez D, Pearson OH. Metabolic effects of placental lactogen (HPL) in man. J Clin Endocrinol Metab 1968;28:485–491.
   PubMedGoogle Scholar
• Burke CW, Roulet F. Increased exposure of tissues to cortisol in late pregnancy. Br Med J 1970;1:657–659.
   PubMed Web of Science ®Google Scholar
• Gustafson AB, Banasiak MF, Kalkhoff RK, Hagen TC, Kim HJ. Correlation of hyperprolactinemia with altered plasma insulin and glucagon: Similarity to effects of late human pregnancy. J Clin Endocrinol Metab 1980;51:242–246.
   PubMed Web of Science ®Google Scholar
• Lepore G, Dodesini AR, Nosari I, Trevisan R. Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment. Diabetes Care 2003;26:1321–1322.
   PubMedGoogle Scholar
• Simmons D, Thompson CF, Conroy C, Scott DJ. Use of insulin pumps in pregnancies complicated by type 2 diabetes and gestational diabetes in a multiethnic community. Diabetes Care 2001;24:2078–2082.
   PubMed Web of Science ®Google Scholar
• Chase HP, Saib SZ, MacKenzie T, Hansen MM, Garg SK. Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with type 1 diabetes. Diabet Med 2002;19:317–321.
   PubMedGoogle Scholar
• Henriksen JE, Djurhuus MS, Vaag A, Thye-Rønn P, Knudsen D, Hother-Nielsen O, Beck-Nielsen H. Impact of injection sites for soluble insulin on glycaemic control in type 1 (insulin-dependent) diabetic patients treated with a multiple insulin injection regimen. Diabetologia 1993;36:752–758.
   PubMedGoogle Scholar
• Bode BW. Pumping protocol. A physician’s guide to insulin pump therapy initiation. 1997. Minimed Inc. Publication.
   Google Scholar
• Heinemann L, Weyer C, Rauhaus M, Heinrichs S, Heise T. Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart. Diabetes Care 1998;21:1910–1914.
   PubMed Web of Science ®Google Scholar
• Anderson JH Jr, Brunelle RL, Koivisto VA, Pfützner A, Trautmann ME, Vignati L, DiMarchi R. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group. Diabetes 1997;46:265–270.
   PubMed Web of Science ®Google Scholar
• Zinman B, Tildesley H, Chiasson JL, Tsui E, Strack T. Insulin lispro in CSII: Results of a double-blind crossover study. Diabetes 1997;46:440–443.
   PubMed Web of Science ®Google Scholar
• Mathiesen ER, Kinsley B, Amiel SA, Heller S, McCance D, Duran S, Bellaire S, Raben A; Insulin Aspart Pregnancy Study Group. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: A randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care 2007;30:771–776.
   PubMed Web of Science ®Google Scholar
• Brunelle BL, Llewelyn J, Anderson JH Jr, Gale EA, Koivisto VA. Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Diabetes Care 1998;21:1726–1731.
   PubMed Web of Science ®Google Scholar
• Homko C, Deluzio A, Jimenez C, Kolaczynski JW, Boden G. Comparison of insulin aspart and lispro: Pharmacokinetic and metabolic effects. Diabetes Care 2003;26:2027–2031.
   PubMed Web of Science ®Google Scholar
• Hedman CA, Lindström T, Arnqvist HJ. Direct comparison of insulin lispro and aspart shows small differences in plasma insulin profiles after subcutaneous injection in type 1 diabetes. Diabetes Care 2001;24:1120–1121.
   PubMed Web of Science ®Google Scholar
• Boskovic R, Feig DS, Derewlany L, Knie B, Portnoi G, Koren G. Transfer of insulin lispro across the human placenta: In vitro perfusion studies. Diabetes Care 2003;26:1390–1394.
   PubMed Web of Science ®Google Scholar
• Hellmuth E, Damm P, Mølsted-Pedersen L, Bendtson I. Prevalence of nocturnal hypoglycemia in first trimester of pregnancy in patients with insulin treated diabetes mellitus. Acta Obstet Gynecol Scand 2000;79:958–962.
   PubMedGoogle Scholar
• Evert AB, Mauseth RS. The new insulin analogs: Using a team approach to implement basal-bolus therapy. Practical Diabetology 2004;23:28–37.
   Google Scholar
• The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes control and complications trial. Diabetes 1997;46:271–286.
   PubMed Web of Science ®Google Scholar
• Kimmerle R, Heinemann L, Delecki A, Berger M. Severe hypoglycemia incidence and predisposing factors in 85 pregnancies of type I diabetic women. Diabetes Care 1992;15:1034–1037.
   PubMed Web of Science ®Google Scholar
• Rosenn BM, Miodovnik M, Holcberg G, Khoury JC, Siddiqi TA. Hypoglycemia: The price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus. Obstet Gynecol 1995;85:417–422.
   PubMed Web of Science ®Google Scholar
• Evers IM, ter Braak EW, de Valk HW, van Der Schoot B, Janssen N, Visser GH. Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy. Diabetes Care 2002;25:554–559.
   PubMed Web of Science ®Google Scholar
• Hellmuth E, Damm P, Mølsted-Pedersen L, Bendtson I. Prevalence of nocturnal hypoglycemia in first trimester of pregnancy in patients with insulin treated diabetes mellitus. Acta Obstet Gynecol Scand 2000;79:958–962.
   PubMedGoogle Scholar
• ter Braak EW, Evers IM, Willem Erkelens D, Visser GH. Maternal hypoglycemia during pregnancy in type 1 diabetes: Maternal and fetal consequences. Diabetes Metab Res Rev 2002;18:96–105.
   PubMed Web of Science ®Google Scholar
• Salvesen DR, Freeman J, Brudenell JM, Nicolaides KH. Prediction of fetal acidaemia in pregnancies complicated by maternal diabetes mellitus by biophysical profile scoring and fetal heart rate monitoring. Br J Obstet Gynaecol 1993;100:227–233.
   PubMedGoogle Scholar
• Kontopoulos EV, Vintzileos AM. Condition-specific antepartum fetal testing. Am J Obstet Gynecol 2004;191:1546–1551.
   PubMed Web of Science ®Google Scholar
• Kline GA, Edwards A. Antepartum and intra-partum insulin management of type 1 and type 2 diabetic women: Impact on clinically significant neonatal hypoglycemia. Diabetes Res Clin Pract 2007;77:223–230.
   PubMed Web of Science ®Google Scholar
• Mayer-Davis EJ, Rifas-Shiman SL, Zhou L, Hu FB, Colditz GA, Gillman MW. Breast-feeding and risk for childhood obesity: Does maternal diabetes or obesity status matter? Diabetes Care 2006;29:2231–2237.
   PubMed Web of Science ®Google Scholar